🇺🇸 FDA
Pipeline program

Inhaled Treprostinil (Tyvaso Nebulizer)

PRO00118083

Phase 2 small_molecule active

Quick answer

Inhaled Treprostinil (Tyvaso Nebulizer) for COPD (Chronic Obstructive Pulmonary Disease) is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
COPD (Chronic Obstructive Pulmonary Disease)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials